Le Lézard
Classified in: Health
Subjects: NPT, SCZ

7 Ohio Living locations named Employer of Choice by LeadingAge Ohio


COLUMBUS, Ohio, Aug. 28, 2019 /PRNewswire/ -- Ohio Living has received Employer of Choice designations for seven of its operations through the 2019-2020 LeadingAge Ohio Employer of Choice Initiative. Ohio Living's locations were seven of only 23 organizations within LeadingAge Ohio's 400+ members to receive this prestigious designation.

(PRNewsfoto/Ohio Living)

"Through this program, members demonstrate that they strive not just to be residences or providers of choice, but to be employers of choice as well," said LeadingAge Ohio President & CEO Kathryn Brod. "The Employer of Choice designation recognizes our members that are making strides to distinguish their organizations from competitors on metrics related to employee satisfaction, staffing-related outcomes, and other measures of workplace excellence."

Employer of Choice designations are presented at Gold, Silver and Bronze levels. Receiving Silver designations are Ohio Living Home Health & Hospice operations in greater Akron, greater Dayton, greater Toledo and greater Youngstown. Receiving Bronze designations are Ohio Living Dorothy Love (Sidney), Ohio Living Mount Pleasant (Monroe), and Ohio Living Home Health & Hospice in greater Cincinnati.

"Our 3,200 teammates consistently tell us that our culture is the feeling of family," says Ohio Living CEO Laurence C. Gumina. "We hire team members with a passion for bringing their best to work each day, and we are committed to creating an environment where they will thrive." 

The LeadingAge Ohio Employer of Choice recognition program requires applicants to have a 3-star or better rating on the Centers for Medicare & Medicaid Services Five-Star Quality Rating System, and an occupancy rate of 80% or higher for at least one year.

Other criteria include:

For more about LeadingAge Ohio's Employer of Choice program, visit https://www.leadingageohio.org/aws/LAO/pt/sp/employee_recognition.

About Ohio Living
Headquartered in Columbus, Ohio Living is one of the nation's largest not-for-profit, multi-site aging services organizations, operating 13 life plan communities, Ohio Living Home Health & Hospice and Ohio Living Foundation. Ohio Living is Great Place to Worktm-Certified and ranked on Fortune's list of Best Workplaces in Aging Services.

About LeadingAge Ohio
LeadingAge Ohio is a nonprofit organization that represents over 400 long-term care organizations and hospices, as well as those providing ancillary health care and housing services. The continuum of care reflected by the member organizations serve an estimated 400,000 Ohioans daily and employ over 35,000 persons statewide.

CONTACT: 
Melissa Dardinger, Corporate Manager of Public Relations
614.888.7800 
mdard@ohioliving.org

SOURCE Ohio Living


These press releases may also interest you

at 10:06
Eisai Inc. presented the latest healthcare economic (HCEI) data for FYCOMPA® (perampanel) CIII at the 2019 American Epilepsy Society Annual Meeting in Baltimore, Maryland. Cumulatively, more than 35 scientific abstracts on FYCOMPA were presented by...

at 10:05
Xencor, Inc. , a clinical-stage biopharmaceutical company developing monoclonal antibodies for the treatment of cancer, autoimmune disease, asthma and allergic diseases, today announced initial data from its ongoing Phase 1 dose-escalation study of...

at 10:05
Seattle Genetics, Inc. and Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) today announced additional analyses of results from the ECHELON-1 and ECHELON-2 frontline phase 3 trials of ADCETRIS® (brentuximab vedotin). These analyses were...

at 10:05
Takeda Pharmaceutical Company Limited (TSE: 4502/NYSE:TAK) ("Takeda"), today presented nine hematology poster presentations at the 61st American Society of Hematology (ASH) Annual Meeting that underscore its commitment to advancing treatments for...

at 10:05
Celularity, Inc. ("Celularity"), a clinical-stage cell therapeutics company focused on the development of innovative allogeneic cellular therapies derived from post partum human placentas, announced data introducing an extensive platform in...

at 10:05
Nektar Therapeutics today announced three presentations at the 61st American Society of Hematology (ASH) Annual Meeting & Exposition for its IL-15 agonist and investigational candidate, NKTR-255. Data were presented from a number of preclinical...



News published on 28 august 2019 at 13:15 and distributed by: